Periodic Reporting for period 5 - GLORIA (Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis)

GLORIA aims to prove that the add-on, low dose prednisolone to current antirheumatic therapy is cost-effective and safe in elderly patients with rheumatoid arthritis (RA). The main component of GLORIA is a large pragmatic trial: 450 elderly (>65y) RA patients receiving...